Home › Free Stock Grades › STRO
Sutro Biopharma, Inc. (STRO) Stock Grade
STRO · Healthcare
A+
Market Cap
$98.3M
P/E Ratio
—
Revenue Growth (YoY)
+65.2%
Net Margin
-186.5%
Return on Equity
144.3%
Dividend Yield
None
About Sutro Biopharma, Inc.'s fundamentals
Sutro Biopharma is a small-cap biotechnology company with a market capitalization of $98.3 million that is experiencing strong revenue growth at 65.2% year-over-year. However, the company is currently unprofitable, posting a net margin of -186.5% and reporting a net loss in its latest annual statement, which reflects typical early-stage biotech operations. The company does not pay a dividend, consistent with its focus on reinvesting capital into research and development rather than returning cash to shareholders.